ArticleThe American journal of case reports2026
An Uncommon Presentation of Heyde Syndrome: Absence of Visible Endoscopic Angiodysplasia With Resolution After Transcatheter Aortic Valve Replacement.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Heyde syndrome (HS) is defined by the triad of aortic stenosis (AS), gastrointestinal bleeding, and acquired von Willebrand syndrome (avWS). Diagnosis can be challenging in elderly patients with multiple comorbidities, particularly when angiodysplasia is absent on endoscopy. We present a case illustrating the diagnostic process and therapeutic outcome, emphasizing that the absence of angiodysplasia should not exclude HS. CASE REPORT A 73-year-old woman with a history of AS, coronary artery disease, hypertension, type 2 diabetes, and anemia presented with 2 weeks of melena and 1 week of fatigue. She was pale on exam with a harsh systolic murmur radiating to the carotids. Laboratory evaluation showed hemoglobin 7.7 g/dL, microcytosis, and elevated troponin consistent with type II myocardial infarction due to demand ischemia. Prior endoscopic evaluations, including esophagogastroduodenoscopy, colonoscopy, and capsule studies, revealed melena but no bleeding source. Coagulation studies assessing von Willebrand factor activity were not available from the referring facility in this case. Transthoracic echocardiogram and cardiac catheterization confirmed severe AS (aortic valve area 0.4-0.7 cm2) with concomitant coronary artery disease. The patient underwent transcatheter aortic valve replacement (TAVR). At 6-month follow-up, she was asymptomatic, with resolution of anemia (hemoglobin 14 g/dL) and negative fecal occult blood testing. CONCLUSIONS Acquired von Willebrand factor deficiency diagnostic measures were unable to be provided from the facility at which she was originally admitted. This case underscores the importance of considering HS in patients with severe AS and recurrent gastrointestinal bleeding even when angiodysplasia is not visualized. Hemodynamic shear stress in AS leads to degradation of high-molecular-weight von Willebrand factor multimers, predisposing to bleeding. The resolution of anemia and bleeding after TAVR strongly supports the diagnosis. Early recognition and valve replacement are essential for effective management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.